Assessing Hp Diagnosis and Treatment Quality of direct-to Consumer Telemedicine in Mainland China

CompletedOBSERVATIONAL
Enrollment

552

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Helicobacter Pylori Infection
Interventions
OTHER

Background of different SP information

Sp was asked with the following baseline information: 1. 50 years of age and gender; 2. positive urea breath test; 3. asymptomatic; 4. family history of gastric cancer; 5. gastroscopy: atrophic gastritis; 6. untreated; and 7. no history of drug allergies.

Trial Locations (1)

Unknown

Qilu Hospital of Shandong University, Jinan

All Listed Sponsors
lead

Shandong University

OTHER

NCT06749873 - Assessing Hp Diagnosis and Treatment Quality of direct-to Consumer Telemedicine in Mainland China | Biotech Hunter | Biotech Hunter